FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

816080008: International Patient Summary (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3850164019 International Patient Summary en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
3850165018 International Patient Summary (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)


12930 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
International Patient Summary Is a Simple type reference set (foundation metadata concept) true Inferred relationship Some

Members
Product containing precisely magnesium sulfate heptahydrate 500 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mannitol 100 mg/mL solution for injection
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely mebendazole 100 milligram/1 each conventional release chewable tablet (clinical drug)
Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug)
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection (clinical drug)
Medroxyprogesterone acetate 160 mg/mL suspension for injection
Medroxyprogesterone acetate 5 mg oral tablet
Product containing precisely mefloquine (as mefloquine hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug)
Meglumine antimoniate 300 mg/mL solution for injection
Product containing precisely melarsoprol 36 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Melphalan 2 mg oral tablet
Mercaptopurine 50 mg oral tablet
Product containing precisely meropenem 1 gram and vaborbactam 1 gram/1 vial powder for conventional release solution for injection (clinical drug)
Meropenem 1 g powder for solution for injection vial
Product containing precisely meropenem 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug)
Product containing precisely mesalazine 1 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Product containing precisely mesalazine 1 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet
Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet
Mesalazine 250 mg rectal suppository
Mesalazine 250 mg gastro-resistant and prolonged-release oral tablet
Mesalazine 250 mg gastro-resistant and prolonged-release oral tablet
Product containing precisely mesalazine 4 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug)
Product containing precisely mesalazine 4 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug)
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Mesalazine 500 mg rectal suppository
Product containing precisely mesalazine 500 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Product containing precisely mesalazine 500 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)
Mesalazine 66.7 mg/mL rectal suspension
Mesalazine 800 mg gastro-resistant and prolonged-release oral tablet
Mesalazine 800 mg gastro-resistant and prolonged-release oral tablet
Mesna 100 mg/mL solution for injection
Mesna 400 mg oral tablet
Mesna 600 mg oral tablet
Metformin hydrochloride 500 mg oral tablet
Methadone hydrochloride 1 mg/mL oral solution
Methadone hydrochloride 10 mg oral tablet
Product containing precisely methadone hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)
Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Methadone hydrochloride 5 mg oral tablet
Product containing precisely methadone hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)
Methotrexate (as methotrexate sodium) 100 mg/mL solution for injection
Methotrexate (as methotrexate sodium) 2.5 mg oral tablet
Methotrexate (as methotrexate sodium) 2.5 mg/mL solution for injection
Methotrexate (as methotrexate sodium) 20 mg/mL solution for injection
Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection
Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection
Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection
Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection
Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug)
Methyldopa 250 mg oral capsule
Methyldopa 250 mg oral tablet
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial
Product containing precisely methylthioninium chloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)
Metoclopramide hydrochloride 10 mg oral tablet
Metoprolol tartrate 100 mg oral tablet
Metoprolol tartrate 25 mg oral tablet
Metoprolol tartrate 50 mg oral tablet
Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension
Metronidazole 1 g rectal suppository
Metronidazole 200 mg oral tablet
Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for injection (clinical drug)
Metronidazole 500 mg oral tablet
Metronidazole 500 mg rectal suppository
Miconazole nitrate 20 mg/g cutaneous cream
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug)
Product containing precisely midazolam (as midazolam hydrochloride) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely midazolam (as midazolam hydrochloride) 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug)
Midazolam (as midazolam hydrochloride) 2 mg/mL oral solution
Midazolam (as midazolam hydrochloride) 5 mg/mL oromucosal solution
Product containing precisely midazolam (as midazolam maleate) 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug)
Product containing precisely midazolam (as midazolam maleate) 15 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely midazolam (as midazolam maleate) 7.5 milligram/1 each conventional release oral tablet (clinical drug)
Mifepristone 200 mg oral tablet
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug)
Miltefosine 50 mg oral capsule
Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug)
Misoprostol 25 microgram vaginal tablet
Morphine sulfate 10 mg oral tablet
Product containing precisely morphine sulfate 10 milligram/1 each prolonged-release oral tablet (clinical drug)
Morphine sulfate 10 mg/mL solution for injection
Morphine sulfate 100 mg prolonged-release oral tablet
Morphine sulfate 100 mg prolonged-release oral granules sachet
Product containing precisely morphine sulfate 15 milligram/1 each prolonged-release oral tablet (clinical drug)
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Product containing precisely morphine sulfate 20 milligram/1 sachet prolonged-release oral granules (clinical drug)
Product containing precisely morphine sulfate 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Product containing precisely morphine sulfate 200 milligram/1 sachet prolonged-release oral granules (clinical drug)
Morphine sulfate 30 mg prolonged-release oral tablet
Product containing precisely morphine sulfate 30 milligram/1 sachet prolonged-release oral granules (clinical drug)
Morphine sulfate 60 mg prolonged-release oral tablet

Start Previous Page 89 of 130 Next End


Reference Sets

International Patient Summary

Reference set descriptor

Back to Start